Healthtech company Radicle Science has obtained a multimillion-dollar investment from Resilience Reserve, a venture capital firm founded by author and entrepreneur Rob Reid and long-time chief curator and head of the TED Conference, Chris Anderson.

The investment will help strengthen Radicle’s ability to expand its patent-pending, Proof-as-a-Service high-throughput clinical evidence generation engine.

“Radicle Science has pioneered a remarkable ability to put non-pharmaceutical products through large, rigorous clinical trials, thereby unlocking powerful new possibilities for affordable treatments,” Anderson said. “Discovering companies that have figured out how to do something important in an entirely new way is super exciting.”

Radicle has meanwhile been invited to participate in two distinctive programs that highlight and advance its breakthroughs in evidence generation. The startup has been selected for the One Mind Accelerator, a program for early-stage companies developing breakthrough mental health solutions. Fewer than 5% of the applying companies were accepted into this year’s class.

Radicle has also been invited into three separate Plug & Play Silicon Valley innovation cohorts, which hosts multiple industry-focused accelerators in fields including health, deeptech, and food & beverage. Each cohort convenes promising early-stage companies with mentors, investors, and corporate partners.

Radicle’s platform combines consumer science and AI with large placebo-controlled clinical trials to generate gold-standard evidence on non-prescription therapies across diverse populations.

Founded in 2020 by Pelin Thorogood, M.Eng/MBA, and Jeff Chen, MD/MBA, the company said it conducts placebo-controlled clinical trials on more Americans each year than all FDA drug trials combined.

“We’re incredibly energized by the conviction Chris and Rob are bringing to our mission,” said Chen and Thorogood. “Their belief in evidence, ideas worth testing, and expanding the envelope of accessible treatments aligns deeply with our reasons for founding Radicle. And their capital will allow us to both scale and accelerate our vision.”

“Meanwhile, our work with the One Mind Accelerator and Plug & Play puts us in ecosystems that are shaping the future of consumer health,” they added. “Together, Radicle and Resilience Capital aim to bring clinical validation to real wellness innovations faster, more precisely, more inclusively, and more credibly.”